Chargers suffer major blow as star left tackle Rashawn Slater sustains season-ending injury, forcing roster adjustments and raising concerns about the team's prospects.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.
Chargers suffer major blow as star left tackle Rashawn Slater sustains season-ending injury, forcing roster adjustments and raising concerns about the team's prospects.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.